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Abstract
Artiﬁcial intelligence has illustrated drastic changes in radiology and medical imaging techniques which in turn led to
tremendous changes in screening patterns. In particular, advancements in these techniques led to the development of
computer aided detection (CAD) strategy. These approaches provided highly accurate diagnostic reports which served as
a “second-opinion” to the radiologists. However, with signiﬁcant advancements in artiﬁcial intelligence strategy, the
diagnostic and classifying capabilities of CAD system are meeting the levels of radiologists and clinicians. Thus, it shifts
the CAD system from second opinion approach to a high utility tool. This article reviews the strategies and algorithms
developed using artiﬁcial intelligence for the foremost cancer diagnosis and classiﬁcation which overcomes the challenges in the traditional method. In addition, the possible direction of AI in medical aspects is also discussed in this
study.
Keywords: Artiﬁcial intelligence, Artiﬁcial neural network, Breast cancer, Gastric cancer, Lung cancer

1. Introduction

C

ancer being one of the non-communicable
diseases is ranked at the foremost for being
the blockade of survival rate among the global
population. For instance 1.8 million new cases
and 9.6 million deaths were estimated worldwide
in 2018. Among them 59.5% of global cancer
deaths had occurred in Asia. Moreover cancer in
lung, breast, pancreatic, gastric and skin were the
signiﬁcant contributors for the highest incidence
rate in 2018 [1]. Due to the rise of cancer incidence
rate, diagnosing of disease using conventional
tools at early stage had become difﬁcult. Moreover, these traditional methods experienced
diagnostic errors including missed, wrong and
delayed cases [2]. On the other hand, understanding the perplexity of cancer at different
stages has complicated the research further. The

perplexity of cancer includes early detection, accuracy, tumor evolution, metastasis pattern,
recurrence, tumor aggressiveness and determination of tumor margins [3]. To overcome the
limitations mentioned above and to diagnose
cancer at the earliest, advancement in artiﬁcial
intelligence (AI) had been raised for quantifying
the imaging data.
Deep learning, a section in AI, plays a promising
role in automated recognition of features from
sample medical images beyond human's role in
particular tasks [4]. For instance automated applications of AI enhanced the qualitative potentials of
clinicians, which includes tracing numerous lesions
at a time, prediction of the resultant tumor by
referring to the various databases within a short
period, translation of phenotypic variations to
genotypic and persistent monitoring of patients.
Despite the need for a large quantity of data for
training, deep learning had illustrated relative
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Fig. 1. Overall process involved in tumor diagnosis and classiﬁcation.

stability against random ﬂuctuations in the ground
truth features [5]. Furthermore it generalizes disease
imaging techniques with minimal errors which in
turn lead to earlier and signiﬁcant diagnosis of
diseases.
Besides deep learning, artiﬁcial neural network
(ANN) is also used to classify cancer more precisely.
It is a mathematical model postulated from the
human nervous system comprising of interconnected neurons. Connectionist strategy is
implemented in this technique for computational
processing of information. Eventually to illustrate
the adaptive system, neural network plays a significant role by modifying its structure based on the
training data and by detecting patterns in the data.
ANN can be designed through learning process for

any particular application [6]. On learning the data
during its training time, it organizes itself to proceed
further. Moreover many networks can be performed
simultaneously and also bears fault tolerance by
preventing degradation of structures [7]. Though
these studies are intensively applicable in pre-clinical studies, the automated approach of tumor
diagnosis and classiﬁcation discriminates the cancer
period of time. The overall process involved in
tumor diagnosis and classiﬁcation were briefed in
Fig. 1.
At the light of these evidences, current studies and
future applications of AI to medical imaging in top
incidental cancers were reviewed during this
investigation. This paper highlights the application
of AI that generated a drastic transformation in
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Fig. 2. Schematic representation illustrating overall view of our study.

cancer diagnosis and treatment. In particular, the
study includes case studies which enlightens
application of AI in diagnosis and classiﬁcation of
three cancers (lung, breast and gastric cancer). The
evolution of AI in cancer imaging described in this
study also provides the signiﬁcance of AI in cancer
diagnosis and treatment. Moreover this study also
provides potential applications of AI overcoming
the limitations in cancer imaging including presence

of denser tissues during diagnosis and classiﬁcation
of cancerous samples from non-tumor samples. The
number of case studies concerning AI technology in
lung, breast and gastric cancer clariﬁes the other
characteristics of this latest technology. Overall, the
study shows the signiﬁcant application of AI technology which in turn improves the cancer care in
the society. Moreover, this paper also suggests that
artiﬁcial intelligence application in cancer imaging
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needs further evaluation and validation for
improved reliability and generalizability of approaches in clinical practices [8]. The tree diagram
provided in Fig. 2 illustrates the structure of the
paper for better understanding.

2. Theoretical background
AI in oncology imaging process includes three
major clinical tasks: Diagnosis, characterization and
monitoring. In general, detection involves observation of pathologists over variations in image intensities or complex patterns to understand the
aberrations in the patients. Advanced computational technology-assisted pathologists to predict
and identify cancer with more accuracy and fewer
errors. This strategy of detection is known as
Computer Aided Detection (CAD) [9]. AI based
tools assisted in identiﬁcation of missed cancer patients as well as detection with high accuracy and
sensitivity [10]. The second task characterization
includes diagnosis, segmentation and staging of
cancer. This task quantiﬁes abnormality of features
including size and texture. Segmentation measures
extent of abnormalities in a two dimensional (2D)
plane. Manual segmentation process in clinical
practice limits itself with minimal accuracy, interrater bias, high time and labor consumption and
inconsistent reproducibility [11]. In contrast, AI
based approach provided automated segmentation
with increased quality, reproducibility and
efﬁciency.
Further expansion of technology leads to an integrated method in which separate segmentation
process is not required. This task also includes
staging of disease in which the cancer is explained
based on predeﬁned features and are classiﬁed
based on TNM classiﬁcation [12]. Ensemble
methods were employed in traditional staging task
whereas automated staging relies on tumor size,
metastasis and neighboring lymph node data for
classiﬁcation [13].
On the other hand ANN had become a signiﬁcant
strategy for cancer classiﬁcation. It consists of three
consecutive layers namely input layers, hidden
layers and output layer. ANN can be classiﬁed into
single layer feed forward network, single node with
its own feedback, multi-layer feed forward network
and multi-layer recurrent network. In addition, it
also uses three different learning strategy for
generating neural network which includes supervised learning, unsupervised learning and reinforcement learning. Among them supervised
learning has higher accuracy and precision as it
develops output based on the pattern of each input
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[7]. Hence automated staging is more reliable than
traditional approach. Despite the complexity of data,
artiﬁcial intelligence is remarkable in identifying the
features from large volume of medical data which in
turn is used to assist clinicians [14]. It also identiﬁes
complicated patterns and supports in transforming
images into valuable quantitative information. It is
to be noted that these information are not recognized by humans, thus makes clinical decisions
easier.
Besides, detection and classiﬁcation of cancers
were the major challenges in the medical ﬁeld.
Artiﬁcial intelligence assists clinicians in interpreting cancer images, including cancer stages, tumor
delineations, detection of mutations, the impact of
anti-cancer treatment, and the inﬂuence of disease
on other organs. For instance, Khan et al. had proposed an integrated convolution neural network
algorithm to classify the breast tumor as benign and
malignant, which in turn reduced the burden of
pathologists in tumor classiﬁcation [15]. Similarly, a
deep learning model developed by Kim et al. and
his co-workers assisted the clinicians in predicting
the survival rate of the oral cancer patients, which in
turn helped the medical practitioners to provide
appropriate and effective treatments to the patients
[16].
Moreover, medical input data varies beyond imaging techniques, which include blood biomarkers,
molecular signatures, and statistical data. It is to be
noted that AI is one of the integrative tools that
parallel and normalizes various streams of information. Also, advancements in AI approach assists
human experts to visualize, understand, and
analyze the results [17]. Besides medical imaging,
the application of AI in health monitoring enhances
efﬁciency with reduced cost.
Despite radiation dose, subsequent measurements, and scan e time, advancements in phasecontrast imaging techniques can assists radiologists
Application of AI in cancer imaging
Number of publications
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Fig. 3. Graph explaining the signiﬁcance of AI in the ﬁeld of cancer
imaging.
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Table 1. Recently proposed algorithms for early diagnosis and classiﬁcation of lung cancer.
S. No

Paper

Year

Input images

Dataset

Purpose

Classifier

Results

1

ALzubi et al. [28]

2019

Thoracic surgery
dataset

1200

Lung cancer diagnosis

Feature selection rate - 90%

2
3

Pandiangan et al. [29]
Nasser et al. [30]

2019
2019

X-ray images
Lung cancer dataset

40
NA

Lung cancer detection
Lung cancer detection

4

Roy et al. [31]

2019

Lung CT images

100

Lung cancer detection

Weight Optimized NN with
Maximum Likelihood
Boosting classification
ANN
Feed forward back
propagation neural network
SVM and Random forest
algorithm

5

Bhalerao et al. [32]

2019

Lung CT images

90

Lung cancer detection

Maxpooling and ReLU
algorithm

6

Senthil et al. [26]

2018

Lung cancer image dataset

NA

Partial swarm optimization

7

Perumal et al. [33]

2018

Lung CT images

100

Early detection of lung
cancer
Lung cancer detection and
classification

8

Xin Li et al. [34]

2018

Chest CT images

NA

Stage 1 diagnosis

CNN

9

Wang et al. [25]

2018

Histopathology images

539

CNN

10

Coudray et al. [27]

2017

Histopathology images

1175

Discovery of tumor shape and
boundary
Classification and mutation
predication in NSCLC

Inception v3

Efficacy - 94.5%
Sensitivity - 74.2%
Speciﬁcity - 77.6%
Accuracy e 94.34%
Sensitivity e 91.755
Speciﬁcity e 95.7%
Precision e 91.75%
Accuracy - 97.8%
Sensitivity - 94.8%
Sensitivity - 92%
True positivity rate - 92%
False error rate - 7.6%
Sensitivity - 96.4%
Speciﬁcity - 95.6%
Accuracy - 89.8%
Sensitivity - 97%
Speciﬁcity - 97%

NN e Neural Network, ANN eArtiﬁcial Neural Network, SVM e Support Vector Machine, CNN e Convolution Neural Network, NSCLC e Non Small Cell Lung Cancer.
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Artificial bee colony
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Accuracy - 99%
Accuracy - 96.67%
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S. No

Paper

Year

Input Data type

Dataset

Purpose

classifier

Results

1

Batra et al. [48]

2020

Mammograms

161

Breast cancer detection

Max pooling

2

Ali et al. [49]

2020

Mammograms

50

Breast cancer classification

Tetrolet transform based kmeans classifier

3
4

Kim et al. [50]
Wadkar et al. [51]

2020
2019

Mammograms
Mammograms

17230
5000

Detection of breast cancer
Breast cancer detection

CNN
ANN and SVM

5

Alejandro et al. [52]

2019

Mammograms

240

Detection and classification
of breast cancer

CNN

6

Alickovic et al. [53]

2019

Breast cancer dataset

699

Perceptron neural network

7

Rodriguez-Ruiz et al. [54]

2019

9000

Features classifier

Accuracy - 84%

8

Watanabe et al. [55]

2019

Mammograms and breast
tomosynthesis
Breast cancer dataset

317

Detection and classification
of breast cancer
Detection of calcifications
and soft lesions
Breast cancer detection

Accuracy (Tensorflow) 87.98%
Accuracy (Matlab) 84.02%
Accuracy -92%
Sensitivity - 88%
Speciﬁcity - 96%
Accuracy - 95.9%
Accuracy (artificial neural
network) - 97%
Accuracy (Support Vector
Machine) - 91%
Accuracy - 89%
Sensitivity - 86%
Speciﬁcity - 79%
Accuracy - 99.27%

Accuracy - 90%

9

Wang et al. [56]

2019

Mammograms

400

Breast cancer detection

Artificial intelligence-based
computer-aided detection
Unsupervised extreme
learning machine classifier

10

Huang et al. [57]

2017

Breast cancer dataset

102993

Breast cancer prediction

SVM
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Table 2. Recently proposed algorithms for early diagnosis and classiﬁcation of breast cancer.

Accuracy of Single feature
model - 76.25%
Double feature model 80.75%
Multi feature model 84.5%
Accuracy - 99.41%

CNN e Convolution Neural Network, ANN eArtiﬁcial Neural Network, SVM e Support Vector Machine.
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Table 3. Recently proposed algorithms for early diagnosis and classiﬁcation of gastric cancer.
Paper

Year

Input data type

Dataset

Purpose

Classifier

Results

1

Aslam et al. [69]

2020

Saliva

220

SVM

2

Li et al. [70]

2019

Endoscopic images

2429

Classification of gastric
cancer into early and
advanced stage
Early diagnosis of gastric
cancer

3

Guimar~aes et al. [71]

2019

OGDE images

200

CNN

4
5

Wang et al. [72]
Gao et al. [73]

2019
2019

Gastroscopy images
tomography images

104864
1371

CNN and SVM
Faster region based CNN

Accuracy - 92.10%
Accuracy 95.45%

6
7

Leon et al. [74]
Cho et al. [75]

2019
2019

Histopathological images
Endoscopic images

40
5017

CNN
Inception Resnet v2 model

Accuracy - 89.72%
Accuracy - 84.6%

8

Wu et al. [63]

2018

OGDE images

24549

Detection of gastric
precancerous condition
Screening of gastric cancer
Detection of metastatic
lymph nodes for gastric
cancer classification
Detection of gastric cancer
Detection of gastric
neoplasms
Early detection of gastric
cancer

Accuracy - 97.18%
Sensitivity - 96.88%
Speciﬁcity - 97.44%
Accuracy - 90.91%
Sensitivity - 91.18%
Speciﬁcity - 90.64%
Accuracy - 93%

Deep CNN

9

Sakai et al. [76]

2018

Endoscopic images

926

Accuracy - 92.5%
Sensitivity -94%
Speciﬁcity - 91%
Accuracy - 82.8%

10

Zhu et al. [67]

2018

Endoscopic images

790

Automatic detection of
gastric cancer
Prediction of invasion depth
for endoscopic resection

Inception v3

Transferring CNN
CNN - computer aided
detection system

Accuracy - 89.66%
Sensitivity - 76.47%
Speciﬁcity - 95.56%

OGDE images - Oesophagogastroduodenoscopic images, SVM e Support Vector Machine, CNN - Convolution Neural Network.
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in detecting tumors. This improvement in combination with AI analysis prevents the revisiting of
patients with decreased false-positive rates [4,18].
Moreover, advancements in digital pathology will
be more quantitative than radiology [19]. With more
advancements in AI, we expect designing of FDA
approved standard protocols for cancer diagnosis,
classiﬁcation, and management.

3. Methodology
In order to manifest the potential of artiﬁcial intelligence in cancer imaging, the following case
studies were described in this paper:
 Application of artiﬁcial intelligence techniques detection and
classiﬁcation of
B
lung cancer
B
Breast cancer
B
Gastric cancer

Furthermore, to show the advancements of AI in
the ﬁeld of cancer, the following search terms were
used in the advanced search tool [20]:
 Application of artiﬁcial intelligence in lung cancer imaging
technique
 Application of artiﬁcial intelligence in breast cancer imaging
technique
 Application of artiﬁcial intelligence in gastric cancer imaging
technique

The evolution of artiﬁcial intelligence in cancer
imaging was carried out for a period of ﬁve years
(January 2015 to May 2020). In order to understand
the signiﬁcance of AI in cancer, the graphical analysis of the evolution of AI in cancer imaging in the
corresponding cancer type is illustrated in Fig. 3. In
particular, the recent development of AI in cancer
imaging techniques after 2017 is brieﬂy discussed in
this study. Selective research works having valuable
contributions in the lung, breast and gastric cancer
diagnosis and classiﬁcation is tabulated in Table 1, 2
and 3 respectively.

4. Results and Discussion
Recent statistical analysis had reported a drastically increased death rate in lung cancer, breast
cancer and gastric cancer worldwide [21]. Hence,
early detection and classiﬁcation with high accuracy
had become essential. In turn, the contribution of
researchers towards detection and classiﬁcation had
been increased. Fig. 3 shows the signiﬁcance of AI in
cancer imaging by researchers.
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4.1. Current trends in lung cancer diagnosis and
classiﬁcation using artiﬁcial intelligence
Lung adenocarcinoma (LADC) being the foremost
cause of death in humans among all other cancers.
The morphological features of LADC are heterogeneous in nature, thus provides variation during
diagnosis. Depending on the tumor size and lymph
location, lung cancer is classiﬁed into four stages:
stage 1 to stage 4. The survival of victim depends on
stages of the cancer which enhances the survival
rate of the victim [22]. Hence early diagnosis plays a
crucial role in lung cancer.
The preliminary diagnosis of lung cancer depends
on the detection of pulmonary nodules. The
computed tomography of both benign and malignant tumors contains pulmonary nodules. Hence
differentiating those into benign and malignant
using visual assessments by the radiologists had
become challenging [23]. Moreover, nodule size is
the most reliable prognosticator of malignancy in
lung cancer. Hence nodule detection had become
crucial in early diagnosis.
Till now, the tissue imaging process is playing an
essential role in lung cancer prognosis. This strategy
depends on morphological features such as tumor
size, shape, and invasion of the tumor cells. It is also
to be noted that these techniques lack a systematic
approach of correlating the features to disease
diagnosis [24]. Additionally, other diagnosing systems such as magnetic resonance imaging (MRI),
sputum cytology, and chest radiography resulted in
poor patient survival due to its lower classiﬁcation
accuracy and higher classiﬁcation error rate. Hence
the application of AI emerged as an effective tool in
lung cancer diagnosis and classiﬁcation.
Recently artiﬁcial intelligence is playing a prominent role in tumor detection, segmentation and classiﬁcation as well as nodule detection in lung cancer.
Moreover, tumor classiﬁcation and metastasis detection from H&E images have been facilitated using
deep learning strategies. For instance, Wang et al. and
his co-workers developed a shape-based diagnostic
model based on features such as age, gender, smoking
status, and disease stage. The ultimate aim of the work
to characterize the shape of the tumor, which is closely
associated with disease prognosis. A convolution
neural network was developed using 539 pathology
images of lung adenocarcinoma patients obtained
from NLST and TCGA repository. The generated
model was validated using a subset of 389 images and
the tumors were detected. The shape features of the
tumor were extracted and analyzed. In addition, the
risk score was used to group the people into low risk
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and high risk respectively. Moreover Kaplan e Meier
method was to predict the survival rate of the patients.
Around 89.8% accuracy was obtained for the prediction of tumor [25]. This study signiﬁcantly proves the
application of AI in lung cancer diagnosis.
Recently, a combined technique of neural network
was proposed by Senthil et al. and his research
scholar to enhance the classiﬁcation accuracy with
minimal error rate. They combined particle swarm
optimization (PSO) algorithm to the neural network
classiﬁer. PSO is a highly cost-effective computational strategy with high speed. The accuracy,
speciﬁcity and sensitivity of the proposed PSOneural network (PSO-NN) was compared with the
standard neural networks such as k-means neural
network (KNN), Bayes network (BN), neural
network (NN) and support vector machine (SVM).
Accuracy of PSO-NN was about 97.8%, whereas the
accuracy of KNN, BN, NN and SVM was found to be
68.9%, 74.6%, 85.4% and 91.5% respectively [26]. The
proposed network suggests that AI can be effectively implemented for lung cancer diagnosis.
Moreover it assists doctors in diagnosing and
medicate patients at the earliest.
Besides the classiﬁcation of lung cancer patients,
the identiﬁcation of mutations plays an important
role in targeted therapy. The deep learning convolutional neural network model built using 1634
histopathology images from TCGA repository
assisted the experts in treating patients through
targeted therapy. In this study, Nicolas et al. used v3
convolutional neural network to classify disease and
to identify the mutations from the images. Using the
proposed model, he achieved around 97% of speciﬁcity and sensitivity for classifying the samples and
86% accuracy for identifying the mutations from the
samples. His ﬁndings suggested the experts to
cancer types and mutation with high accuracy and
less expensive strategy [27]. Thus this proposed
work can provide a promising treatment for lung
cancer patients. Additionally, some research works
contributed to lung cancer diagnosis, and classiﬁcation were tabulated in Table 1.
4.2. Artiﬁcial Intelligence in diagnosis and
classiﬁcation of breast cancer
Breast cancer holds the second position amongst
overall cancer death worldwide. It occurs due to
uncontrolled and abnormal growth of tissues
resulting in lump formation in the breast. Thus it
consequently leads to tumor growth which can be
treated successfully at their early stages [35].
Recently, the most prominent tool “mammography”
has been developed for early diagnosis of breast
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cancer. Regardless mammography had reduced
mortality rate by 30%, it contained certain limitations, including high false-positive rates, unnecessary biopsies, overdiagnosis, and treatment [36].
In addition, analyzing of a mammogram differs
based on the experience and is always found to be
biased due to dense breast tissues [37]. Subsequently, this leads to interval cancers that are
detected prior to biennial screening [38].
Similarly, the presence of masses and microcalciﬁcation (calcium deposition) interferes with the
quality of mammograms. Moreover, the detection of
masses is more challenging than microcalciﬁcation
due to its variation in size and shape, which in turn
produces poor contrast images during mammography. This made the radiologists challenging to
classify them as benign and malignant [39]. Thus
automated image detection and classiﬁcation is
playing a vital role nowadays.
ANN is one of the most widely used tools for
interpreting and decision making of mammography
as well as biopsy screenings. The two major applications of AI in breast cancer are feature analysis
from the images and to implement classiﬁers over
the desired target [40].
In general, morphology of cells and its components are regulated by biological mechanisms such
as differentiation, growth, and development. Earlier
pathologists performed tedious visual approaches
for tumor grading and morphological assessment of
samples. This created larger variations amongst the
senior pathologists [41]. Hence many strategies were
developed for automated image analysis which includes CAD till AI. Recently, AI based strategies
were found to be outperforming in pathology image
analysis [42]. For instance, Rakhlin and his research
group drawn attention for image feature extraction
and their classiﬁcation. Deep convolution neural
network was implemented for extraction of image
features, and gradient boosted trees classiﬁed them
into 2 class as well as 4 class classiﬁcations respectively. Their study reported about 93.8% accuracy
and 97.3% AUC with respect to 2-class classiﬁcation
tasks, whereas the 4-class classiﬁcation reported
only about 87.2% accuracy. Their strategy implemented unsupervised learning for feature extraction
and supervised learning for classiﬁcation. This
study shows a signiﬁcant result for feature extraction and classiﬁcation during pathology image
analysis [43].
In addition, the presence of highly dense breasts
acts as a risk marker during imaging process. It
describes the measure of intensity of ﬁbro-glandular
tissue in the breast. Moreover presence of dense
breast masks cancer and thus reduces the sensitivity
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during imaging. Besides, the manual classiﬁcation
of dense breast images into four qualitative categories based on Breast Imaging and Reporting Data
Systems (BI-RADS) by the radiologists was found to
be more difﬁcult [44]. Several studies using deep
learning have been investigated in mammography
imaging processes. Mohamed et al. and his group
investigated a novel Convolution Neural Network
(CNN) for classifying mammograms into scattered
density and heterogeneously dense samples. The
classiﬁcation performance of CNN was also tested
using the reﬁned mammograms during their
investigation. The AUC of the CNN model was
94.2%. They observed that increasing the number of
mammogram images increased their accuracy from
94.2% to 98.8%. Hence their study demonstrated the
classiﬁcation accuracies between the two groups,
which subsequently enhances clinical assessment of
breast densities [45].
Despite the advancements in breast imaging
techniques, interpreting the patterns have become
more challenging. Besides, it required specialization
and experience. However, the performance by the
radiologists has been depleted due to the high
incidence rate of breast cancer. At the same time,
increased false-positive and recall rates had criticized the application of mammography for imaging
and screening. Regardless of their drawbacks,
mammograms have the property of being singleslice projection images which can be trained easily
using ANN [46]. Becker et al. illustrated a combinatorial approach of deep learning with CNN (d e
CNN) for diagnosing the images with higher accuracy and shorter period of time. They compared the
accuracy of d e CNN with the experienced radiologists. The study reported about 82% AUC for the
model and about 79% AUC for radiologists respectively. The suggested model for analyzing general
mammograms of breast cancer was higher than the
radiologists. In a similar manner, the study suggested that improving the models will assist radiologists and makes clinical assessments easier [47].
Further, the contributions of other researchers are
tabulated in Table 2.
4.3. Recently proposed artiﬁcial intelligence
strategies in gastric cancer diagnosis and
classiﬁcation
Gastric cancer positions third as a fatal disease
and ﬁfth for its high incidence rate in the world [58].
The patients with early gastric cancer rarely bear the
symptoms, but later on, the symptoms progress
gradually. Moreover, the symptoms are much
similar to gastric ulcers, thus it makes it difﬁcult for
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the patients to differentiate them. This pre-requisites the need for early diagnosis of gastric cancer.
The advancement in endoscopy assists in early
diagnosis and substantially reduces the mortality
rate of gastric cancer. Further, early detection helps
us to remove the lesions using endoscopic resection,
which signiﬁcantly improves the patient's health
quality [59]. Therefore it is essential to attain early
diagnosis with high accuracy for identifying lesions
to prevent and treat gastric cancer.
Magnifying endoscopy with narrow band imaging
(M-NBI) is used to inspect glandular epithelium by
observing microsurface structure and microvascular
architecture. It has better accuracy than light
endoscopy to distinguish non-cancerous and gastric
cancer lesions [60]. Several investigations had reported that the sensitivity and speciﬁcity of identifying gastric cancer lesions using M-NBI was 85.797.3% and 84.4-96.8% respectively [61]. However,
the differentiation ability between cancerous and
non-cancerous lesions using M-NBI by non-experts
was disappointing. To prevail over the limitations
above, AI was implemented to enhance the accuracy
of medical diagnosis.
Endoscopy is a widely used tool for diagnosing
early stage of gastric cancer, among which 7.2% of
patients were misdiagnosed. The meager changes in
mucosa are often not detected during endoscopic
analysis. This requires trained endoscopists with
well-armed knowledge [62]. Hence Deep Convolution Neural Network (DCNN) gained attention for
predicting and analyzing endoscopic images. Wu
et al. detected early gastric cancer lesions with 92.5%
accuracy and 94% speciﬁcity using DCNN. The
diagnosing accuracy and stability were higher than
the trained endoscopists. The time taken by DCNN
model for diagnosing the lesions was comparatively
lower than the endoscopists. Additionally, his study
supported the generation of grid model over the
stomach which covers the suspicious lesion regions
too [63].
DL technology was initially implemented by Hirasawa et al. for the diagnosis of early gastric cancer
in the year 2018. Researchers used images from
conventional endoscope rather than from FICE and
magnifying NBI. Single-shot multi-box pattern was
used for the construction of CNN model. About
13,000 images were used as training set and 2296
images as test set for validating the performance of
the model. Around 77 images in the test set were
found with the lesions. The model categorized the
test set in 47 seconds by ﬁnding 71 lesions containing images accurately with 92% overall sensitivity of the system. The CNN model detected and
processed a stockpile of endoscopic images [64].
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Endoscopic submucosal dissection is another
approach for treating gastric cancer with minimal
invasive depth. This technique is highly preferable
by the patients since it requires shorter stay at
hospitals [65]. However, endoscopic submucosal
dissection are performed to the patients with invasive depth till submucosal layer of stomach based
on the guidelines. In addition, the invasion depth
can also be determined using endoscopic interventions for early gastric cancer by spraying indigo carmine dye. Moreover, the conventional
endoscopy resulted in 69% to 79% accuracy [66].
This shows that there is no reliable tool available for
measuring the invasive depth in gastric cancers.
Recently CAD has been implemented for differential diagnosis of diseases. In 2018, Zhu et al. determined the invasive extent using CNN e CAD
through transfer learning. About 89.16% accuracy
was achieved in measuring the invasive depth with
76.47% sensitivity and 95.56% speciﬁcity. The
developed CNN e CAD model differentiated earlier
gastric cancer from submucosal invasion. This study
also reduced misconception of invasion depth,
which reduces trivial gastrectomy procedures [67].
Other contributions in gastric cancer imaging are
consolidated in Table 3.
Another investigation by Kanesaka et al.
improved the strategy by developing software to
identify and delineate the boundaries between
cancerous and non-cancerous regions. Support
vector machines were implemented in this study to
analyze the gray-level matrix features of narrowband images. One hundred twenty-six images were
used as a training set, and 81 images were used as a
test set for constructing the model. The sensitivity
and speciﬁcity of the model for cancer from noncancerous imaged were validated and found to be
97% and 95%, respectively. Similarly, the sensitivity
and speciﬁcity of area concordance were 66% and
81%, respectively [68].

5. Conclusion
Artiﬁcial intelligence has emerged as a powerful
tool in cancer prognosis and management. Advancements in AI can be effectively implemented in
personalized treatment and monitoring patient's
health leading to a higher quality of care. Other
areas in cancer such as follow up of patient's health,
biochemical tests require the assistance of AI to help
clinicians. Although the application of AI is beneﬁcial, correct steps must be taken for framing the
workﬂow in concern with the medical context to
prevent undesired side effects in patients. Over
time, this strategy may become a standard approach
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for human incidental disease diagnosis, evaluation,
and reporting of data.
For bioinformaticians, image computing and machine learning assists in discovering prominent features for diagnosis and treatment, overcoming the
aforementioned opportunities and challenges. It also
assists researchers in developing new algorithms for
disease characterization using radiology, molecular,
and histology data. In this study, the limitations in the
diagnosis and management of cancer diagnosis and
classiﬁcation was addressed. Also, the application of
AI in tumor detection and classiﬁcation using diagnostic images was discussed. A constant increase in
the number and complexity of cancer images has
reduced the time for evaluating the images by the radiologists. Due to the massive volume of images,
prediction of tumors at the earliest has become one of
the signiﬁcant areas to be inﬂuenced by artiﬁcial intelligence. Moreover, progress in AI research will
provide more solutions to the radiologists for predicting cancers. In the mere future, artiﬁcial intelligence will transcend as a prominent tool in clinical
research.
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